# Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease

> **NCT02360527** · — · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 126 (actual)

## Conditions studied

- Retinal Neurodegeneration
- Alzheimer´s Disease
- Type 2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02360527
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02360527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02360527, "Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02360527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*